Jefferies analyst Roger Song confirmed a Buy rating and a price target of $8.00 for IO Biotech (NASDAQ:IOBT) shares. The ...

Don Schneider, Piper Sandler deputy head of U.S. policy, and Marc Goldwein, CRFB SVP and senior policy director, join CNBC's ...

On Thursday, Piper Sandler adjusted its outlook for Hain Celestial Group Inc. (NASDAQ:HAIN), reducing the price target to $7.00 from the previous $8.00, while keeping a Neutral stance on the ...

"I'm in, I believe, a few scenes," Travis Kelce said of his role in the upcoming 'Happy Gilmore' sequel David Eulitt/Getty; Todd Owyoung/NBC/Getty For Travis Kelce, working with Adam Sandler on ...

Piper Sandler analyst Arvind Ramnani maintained a Buy rating on Epam Systems (EPAM – Research Report) today and set a price target of $258.00. The company’s shares closed last Friday at $225.62.

Katie Piper has shared her decision to try out an “artificial eye”, 16 years after an acid attack that left her partially blind. The 41-year-old activist and Loose Women host has undergone ...

Katie Piper suffered an acid attack in 2008 on the orders of her ex-boyfriend Katie Piper has decided to get an "artificial eye" more than 16 years after an acid attack which left her with serious ...

Katie Piper has decided to get an "artificial eye" more than 16 years after an acid attack which left her with serious injuries and permanent scarring. The TV presenter shared the news on ...

Katie Piper has unveiled her new prosthetic eye after ‘years battling’ with her eye health. The Loose Women star, 41, was left blind in one eye when she was the victim of an acid attack in ...

Fintel reports that on January 10, 2025, Piper Sandler upgraded their outlook for NIKE (SNSE:NKECL) from Neutral to Overweight. There are 3,293 funds or institutions reporting positions in NIKE.

Investing.com -- Piper Sandler upgraded Nike (NYSE:NKE) to Overweight from Neutral, setting a price target of $90, up from $72 a share in a note Friday. The decision reflects confidence in CEO Elliott ...